Cargando…

Inactivation of SARS-CoV-2 on Surfaces by Cold-Plasma-Generated Reactive Species

A Cold Atmospheric Plasma (CAP) apparatus was designed and developed for SARS-CoV-2 killing as evaluated by pseudotyped viral infectivity assays. The reactive species generated by the plasma system was fully characterized by using Optical Emission Spectroscopy (OES) measurement under given condition...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Som V., Dienger-Stambaugh, Krista, Jordan, Michael, Wang, Yuxin, Hammonds, Jason, Spearman, Paul, Shi, Donglu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045245/
https://www.ncbi.nlm.nih.gov/pubmed/36978671
http://dx.doi.org/10.3390/bioengineering10030280
_version_ 1784913554352111616
author Thomas, Som V.
Dienger-Stambaugh, Krista
Jordan, Michael
Wang, Yuxin
Hammonds, Jason
Spearman, Paul
Shi, Donglu
author_facet Thomas, Som V.
Dienger-Stambaugh, Krista
Jordan, Michael
Wang, Yuxin
Hammonds, Jason
Spearman, Paul
Shi, Donglu
author_sort Thomas, Som V.
collection PubMed
description A Cold Atmospheric Plasma (CAP) apparatus was designed and developed for SARS-CoV-2 killing as evaluated by pseudotyped viral infectivity assays. The reactive species generated by the plasma system was fully characterized by using Optical Emission Spectroscopy (OES) measurement under given conditions such as plasma power, flow rate, and treatment time. A variety of reactive oxygen species (ROS) and reactive nitrogen species (RNS) were identified from plasma plume with energies of 15–72 eV in the frequency range between 500–1000 nm. Systematic virus killing experiments were carried out, and the efficacy of CAP treatment in reducing SARS-CoV-2 viral infectivity was significant following treatment for 8 s, with further enhancement of killing upon longer exposures of 15–120 s. We correlated killing efficacy with the reactive species in terms of type, intensity, energy, and frequency. These experimental results demonstrate effective cold plasma virus killing via ROS and RNS under ambient conditions.
format Online
Article
Text
id pubmed-10045245
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100452452023-03-29 Inactivation of SARS-CoV-2 on Surfaces by Cold-Plasma-Generated Reactive Species Thomas, Som V. Dienger-Stambaugh, Krista Jordan, Michael Wang, Yuxin Hammonds, Jason Spearman, Paul Shi, Donglu Bioengineering (Basel) Article A Cold Atmospheric Plasma (CAP) apparatus was designed and developed for SARS-CoV-2 killing as evaluated by pseudotyped viral infectivity assays. The reactive species generated by the plasma system was fully characterized by using Optical Emission Spectroscopy (OES) measurement under given conditions such as plasma power, flow rate, and treatment time. A variety of reactive oxygen species (ROS) and reactive nitrogen species (RNS) were identified from plasma plume with energies of 15–72 eV in the frequency range between 500–1000 nm. Systematic virus killing experiments were carried out, and the efficacy of CAP treatment in reducing SARS-CoV-2 viral infectivity was significant following treatment for 8 s, with further enhancement of killing upon longer exposures of 15–120 s. We correlated killing efficacy with the reactive species in terms of type, intensity, energy, and frequency. These experimental results demonstrate effective cold plasma virus killing via ROS and RNS under ambient conditions. MDPI 2023-02-21 /pmc/articles/PMC10045245/ /pubmed/36978671 http://dx.doi.org/10.3390/bioengineering10030280 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Thomas, Som V.
Dienger-Stambaugh, Krista
Jordan, Michael
Wang, Yuxin
Hammonds, Jason
Spearman, Paul
Shi, Donglu
Inactivation of SARS-CoV-2 on Surfaces by Cold-Plasma-Generated Reactive Species
title Inactivation of SARS-CoV-2 on Surfaces by Cold-Plasma-Generated Reactive Species
title_full Inactivation of SARS-CoV-2 on Surfaces by Cold-Plasma-Generated Reactive Species
title_fullStr Inactivation of SARS-CoV-2 on Surfaces by Cold-Plasma-Generated Reactive Species
title_full_unstemmed Inactivation of SARS-CoV-2 on Surfaces by Cold-Plasma-Generated Reactive Species
title_short Inactivation of SARS-CoV-2 on Surfaces by Cold-Plasma-Generated Reactive Species
title_sort inactivation of sars-cov-2 on surfaces by cold-plasma-generated reactive species
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045245/
https://www.ncbi.nlm.nih.gov/pubmed/36978671
http://dx.doi.org/10.3390/bioengineering10030280
work_keys_str_mv AT thomassomv inactivationofsarscov2onsurfacesbycoldplasmageneratedreactivespecies
AT diengerstambaughkrista inactivationofsarscov2onsurfacesbycoldplasmageneratedreactivespecies
AT jordanmichael inactivationofsarscov2onsurfacesbycoldplasmageneratedreactivespecies
AT wangyuxin inactivationofsarscov2onsurfacesbycoldplasmageneratedreactivespecies
AT hammondsjason inactivationofsarscov2onsurfacesbycoldplasmageneratedreactivespecies
AT spearmanpaul inactivationofsarscov2onsurfacesbycoldplasmageneratedreactivespecies
AT shidonglu inactivationofsarscov2onsurfacesbycoldplasmageneratedreactivespecies